Health AI Central
Share:
Peer-Reviewed Publication
Diabetes Spectr2025;38(2):153-160.January 1, 2025Journal Article

Safety of a Novel Continuous Glucose Monitoring-Informed Insulin Bolus Calculator Mobile Application for People With Type 1 or Type 2 Diabetes.

Mansur Shomali1, Colleen Kelly2, Abhimanyu Kumbara1, Anand Iyer1, Jean Park3, Grazia Aleppo4
1Welldoc, Columbia, MD.
2Kelly Statistical Consulting, Carlsbad, CA.
3MedStar Health Research Institute, Baltimore, MD.
4Feinberg School of Medicine, Northwestern University, Chicago, IL.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Managing bolus insulin dosing can be a significant burden for people with diabetes, many of whom have limited numeracy skills. Insulin bolus calculators (IBCs) may improve glycemia as well as treatment satisfaction. OBJECTIVE: The purpose of this study was to demonstrate the safety of a novel, continuous glucose monitoring (CGM)-informed IBC mobile device app that applies trend arrow…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.